Stay updated on Pembrolizumab in HER2+ Gastric Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.

Latest updates to the Pembrolizumab in HER2+ Gastric Clinical Trial page
- Check4 days agoChange DetectedNapoli, Italy, 80131 was renamed to Naples, Italy, 80131, and the page revision updated to v3.5.0.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedAdded a 'Gastric cancer' tag and a link to the Genetic and Rare Diseases Information Center; page revision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check47 days agoChange DetectedA new revision label 'Revision: v3.4.1' appears and the previous 'Revision: v3.4.0' label is removed; this is a minor version update not affecting trial details.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page adds a glossary toggle and new metadata fields (Last Update Submitted that Met QC Criteria, Last Update Posted) plus an updated revision label (v3.4.0). It removes older items (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).SummaryDifference0.1%

- Check68 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in HER2+ Gastric Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.